- GlobeNewswire•3 days ago
Two Distinct IDO Pathway Inhibitors in Clinical Development. Indoximod, Exclusive to NewLink Genetics GDC-0919 in Partnership with Genentech, a Member of the Roche Group AMES, Iowa & NEW YORK, Oct. 25, ...
- GlobeNewswire•4 days agoNewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1, 2016
AMES, Iowa, Oct. 24, 2016-- NewLink Genetics Corporation, today reported that it will release its third quarter 2016 financial results on Tuesday, November 1, 2016. The company has scheduled a conference ...
- GlobeNewswire•8 days ago
AMES, Iowa, Oct. 20, 2016-- NewLink Genetics Corporation today announced that it will webcast its Analyst and Investor Day being held on Tuesday, October 25 at the Convene Meeting Center in New York City. ...
NewLink Genetics Corporation (NLNK)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
|Bid||8.14 x 100|
|Ask||16.98 x 100|
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.90|
|Avg Vol (3m)||314,120|
|Dividend & Yield||N/A (N/A)|